Literature DB >> 29620947

Outcomes of Transhiatal and Intercostal Pleural Drain After Ivor Lewis Esophagectomy: Comparative Analysis of Two Consecutive Patient Cohorts.

Emanuele Asti1, Daniele Bernardi1, Gianluca Bonitta1, Luigi Bonavina1.   

Abstract

BACKGROUND: In a previous proof of concept study, transhiatal pleural drain has been shown to be safe and effective after hybrid Ivor Lewis esophagectomy. Aim of this study was to compare the short-term outcomes of transhiatal and intercostal pleural drainage. PATIENTS AND METHODS: This is an observational retrospective cohort study. Two methods of pleural drainage were compared in patients undergoing hybrid Ivor Lewis esophagectomy. Patients treated with a transhiatal drain connected to a vacuum bag were compared to a historical cohort of patients treated with the conventional intercostal drain connected to underwater seal and suction. Postoperative morbidity, total and daily drainage output, serum albumin levels, and total dose of paracetamol and ketorolac administered on demand were recorded.
RESULTS: Between January 2014 and December 2016, 50 patients with transhiatal drain and 50 with intercostal drains met the criteria for inclusion in the study. Demographic and clinicopathological variables were similar in the two groups. There was no statistically significant difference in the rate of postoperative complications. The total volume of drain output and the serum albumin levels were similar in the two groups. The total dose of ketorolac was significantly reduced in patients with transhiatal drain (P < .001).
CONCLUSIONS: Transhiatal pleural drainage connected to a portable vacuum system could safely replace the intercostal drain after hybrid Ivor Lewis esophagectomy. It has the potential to reduce postoperative pain and use of nonsteroidal anti-inflammatory drugs, and to enhance recovery from surgery.

Entities:  

Keywords:  esophagectomy; intercostal pleural drainage; postoperative pain; transhiatal pleural drainage

Mesh:

Substances:

Year:  2018        PMID: 29620947     DOI: 10.1089/lap.2018.0031

Source DB:  PubMed          Journal:  J Laparoendosc Adv Surg Tech A        ISSN: 1092-6429            Impact factor:   1.878


  1 in total

1.  Minimally invasive esophagectomy for cancer in COVID hospitals and oncological hubs: are the outcomes different?

Authors:  Pamela Milito; Emanuele Asti; Marco Resta; Luigi Bonavina
Journal:  Eur Surg       Date:  2022-03-18       Impact factor: 0.796

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.